ARTICLES
-
-
Year
-
-
- Practices
-
Chinese Mainland Capital MarketsHong Kong & Overseas Capital MarketsInvestment/M&A & Corporate GovernanceCross-border Investment/M&AConstruction & Project DevelopmentFinancingTaxation & Wealth PlanningPrivate Equity & Investment FundsFinancial Products & TrustsLitigation & ArbitrationCorporate & Commercial CrimeShippingCompliance & InvestigationAntitrust & CompetitionTrade Compliance & Trade RemediesCustoms & Import/ExportLabor & EmploymentHealth, Safety & Environmental ProtectionIP Licensing & EnforcementTrademark ProsecutionPatent ProsecutionCybersecurity & Data ProtectionBankruptcy, Insolvency & ReorganizationDebt Restructuring & Non-performing Assets
-
- Industries
-
Real EstateUrban InfrastructureTransportation & LogisticsTourism & HospitalityEnergy & PowerMining & Natural ResourcesBanking & Financial ServicesInsuranceFinancial Innovation & FintechTelecom & InformationIntelligence Technology & ApplicationHealthcarePharmaceuticals & Life SciencesEducation & TrainingMedia, Sports & EntertainmentNational Defense & Military IndustryRetail & Consumer ProductsIndustry & ManufacturingAgriculture & Food
-
- Latest
- Most relevant
-
-
2026-01-13
China New CMO Rule Reshaping Pharmaco BD Deal
NMPA's new CMO rules highlight regulatory compliance in pharma licensing—from diligence to structure and key terms.
-
2025-12-26
Protecting Your Business: Navigating Non-Competes in China
Overview and practical guidance on enforcing non-competes under Chinese laws.
-
2025-12-08
China's CSL Amendment: Six Highlights and Compliance Guidance
The CSL Amendment introduces a more formidable penalty regime while concurrently offering compliance incentives.
-
2025-12-01
Regulatory Compliance: A New Era for China's Biotech Innovation
The Regulation sets unified rules for clinical studies and translational applications of new biomedical technologies.
-
2025-11-22
The Rise of Four New Trade-Remedy Tools in the EU and the U.S.
This article reviews the legal frameworks and procedural attributes of 4 new trade remedy tools in the EU and the U.S..